Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence

Dreyer, S. B., Upstill-Goddard, R., Legrini, A., Biankin, A. V. , Jamieson, N. B. and Chang, D. K. (2022) Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence. Gastroenterology, 162(1), 320-324.e4. (doi: 10.1053/j.gastro.2021.09.022) (PMID:34534536) (PMCID:PMC8721486)

Abstract

No abstract available.

• Item Type: Articles
• Additional Information: Research Funding Support: • Cancer Research UK Postdoctoral research bursary: C54177/A30322 • Wellcome Trust Senior Investigator Award: 103721/Z/14/Z • Cancer Research UK Programme: C29717/A17263 and C29717/A18484 • Cancer Research UK Glasgow Centre: C596/A18076 • Cancer Research UK Clinical Training Award: C596/A20921 • Cancer Research UK Clinician Scientist Award: C55370/A25813 • The National Health & Medical Research Council of Australia, The Cancer Council NSW, Cancer Institute NSW, Royal Australasian College of Surgeons, St Vincent’s Clinic Foundation and R. T. Hall Trust. • The Avner Pancreatic Cancer Foundation
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Jamieson, Professor Nigel and Chang, Professor David and Dreyer, Dr Stephan and Upstill-Goddard, Dr Rosie and Biankin, Professor Andrew and legrini, assya
• Authors: Dreyer, S. B., Upstill-Goddard, R., Legrini, A., Biankin, A. V., Jamieson, N. B., and Chang, D. K.
• College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
• Journal Name: Gastroenterology
• Publisher: Elsevier
• ISSN: 0016-5085
• ISSN (Online): 1528-0012
• Published Online: 14 September 2021
• Copyright Holders: Copyright © 2021 AGA Institute
• First Published: First published in Gastroenterology 162(1): 320-324.e4
• Publisher Policy: Reproduced under a Creative Commons License

Project Code	Award No	Project Name	Principal Investigator	Funder's Name	Funder Ref	Lead Dept
309422		Characterising the immune landscape of molecular subtypes of pancreatic ductal adenocarcinoma	Stephan Dreyer	Cancer Research UK (CRUK)	C54177/A30322	Institute of Cancer Sciences
170634		Defining Platinum and PARP Responsive Molecular Phenotypes of Pancreatic Cancer.	Andrew Biankin	Wellcome Trust (WELLCOTR)	103721/Z/14/Z	Institute of Cancer Sciences
169396		Genotype Guided Stratified Therapy for Pancreatic Cancer	Andrew Biankin	Cancer Research UK (CRUK)	C29717/A17263	Institute of Cancer Sciences
169638		Genotype Guided Stratified Therapy for Pancreatic Cancer	Andrew Biankin	Cancer Research UK (CRUK)	C29717/A18484	CS -Translational Research Centre
190874		CR-UK Centre renewal	Karen Vousden	Not Applicable (NA)	C596/A18076	Institute of Cancer Sciences
172008		Clinical Training Award Cycle 2	Andrew Biankin	Cancer Research UK (CRUK)	C596/A20921	CS -Translational Research Centre
301364		COMBINATION THERAPIES TARGETING IMMUNE EVASION IN PANCREATIC CANCER	Nigel Jamieson	Cancer Research UK (CRUK)	C55370/A25813	CS -Translational Research Centre